Aakaar Medical Technologies Ltd

Fri 23/10/2026,15:50:5 | NSE : AAKAAR

₹63.80-3.35 (-4.99%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 64.05

Previous Close

₹ 67.15

Volume

3200

Mkt Cap ( ₹ Cr)

₹ 90.42

High

₹ 64.05

Low

₹ 63.80

52 Week High

₹ 90.00

52 Week Low

₹ 46.00

Book Value Per Share

₹ 38.49

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Aakaar Medical Technologies Ltd

Your Vote -

Buy

71.43%

Hold

0.00%

Sell

28.57%

71.43%

7 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

57.20

8000

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

8000

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Aakaar Medical Technologies Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Aakaar Medical Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    17 Oct 2026, 11:05AM Aakaar Medical Technologies Limited has informed the Exchange about Schedule of meet
  • Aakaar Medical Tech has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2026

    16 Oct 2026, 10:40PM As of September 2026, 67.05% is owned by Promoters and 32.95% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 63.06% and
  • Aakaar Medical Tech - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    16 Oct 2026, 11:32AM Aakaar Medical Technologies Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Aakaar Medical Tech - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    13 Oct 2026, 7:16PM Aakaar Medical Technologies Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Aakaar Medical Tech - Trading Window

    24 Sep 2026, 1:11PM Aakaar Medical Technologies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) R
  • Aakaar Medical Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    16 Sep 2026, 12:32PM Aakaar Medical Technologies Limited has informed the Exchange about the Outcome of the Meet.
  • Aakaar Medical Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    8 Sep 2026, 4:09PM Aakaar Medical Technologies Limited has informed the Exchange about Schedule of meet
  • Aakaar Medical Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    31 Aug 2026, 4:30PM Aakaar Medical Technologies Limited has informed the Exchange about Outcome
  • Aakaar Medical Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    25 Aug 2026, 12:04PM Aakaar Medical Technologies Limited has informed the Exchange about Schedule of meet
  • Aakaar Medical Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    20 Aug 2026, 12:52PM Aakaar Medical Technologies Limited has informed the Exchange about the Cancellation Of Investors Meet which was scheduled to be held on 21.08.26
  • Aakaar Medical Tech - General Updates

    24 Jul 2026, 11:11PM Aakaar Medical Technologies Limited has informed the Exchange about General Updates
  • Aakaar Medical Tech - Updates

    24 Jul 2026, 10:52PM Aakaar Medical Technologies Limited has informed the Exchange regarding 'Board Comments on Notice dated 14.07.2026 from National Stock Exchange'.

Key fundamentals

Evaluate the intrinsic value of Aakaar Medical Technologies Ltd stock 

Name March-26 March-25 March-24
Assets 73.0849 45.9411 27.5982
Liabilities 73.0849 45.9411 27.5982
Equity 14.1728 10.4224 0.7
Gross Profit 10.3118 9.7369 4.9989
Net Profit 6.6376 6.0395 2.8702
Cash From Operating Activities -8.3613 -5.4063 -8.0441
NPM(%) 9.91 9.8 6.22
Revenue 66.9641 61.5828 46.111
Expenses 56.6523 51.8459 41.1121
ROE(%) 12.16 11.07 5.26

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Aakaar Medical Technologies Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 763.70 -2.63 19.31 0.00 -26.19 0.65
Lotus Eye Hospital and Institute Ltd 112.40 1.47 1605.71 0.00 0.39 0.00
Vaishali Pharma Ltd 6.87 -4.98 21.47 0.00 15.42 0.00
Astec Lifesciences Ltd 663.70 -0.82 0.00 0.00 -363.14 0.00

Company Info

Our Company was originally incorporated as `Aakaar Medical Technologies Private Limited', a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated June 20, 2013 issued by the Registrar of Companies, Mumbai. Subsequently, our Company was converted into a public limited company pursuant to a resolution passed by our shareholders at an extraordinary general meeting held on July 19, 2024 and a fresh certificate of incorporation dated November 18, 2024 was issued by the Registrar of Companies, Mumbai, recording the change in the name of our Company from `Aakaar Medical Technologies Private Limited' to `Aakaar Medical Technologies Limited'.Major Events:2013- Incorporated as Aakaar Medical Technologies Private Limited.2016- Entered into licensing, marketing and distribution agreement with Medytox Inc., South Korea for launch of Siax.2017- Launched our own brands Tubelite.- Launched our own brand Balback.- Launched our own brand Lytec.2018-Entered into a tripartite agreement with ACPL and Croma Pharma GmbH for launch of Saypha filler (earlier known as Princess).2022- Launched our own brand Etrelume.2023- Launched our own brand Swyada.- Entered into exclusive agreement in licensing, marketing and distribution with Regenera Activa Worldwide S.L for launch of Regenera ActivaAMT.- Entered into exclusive agreement in licensing, marketing and distribution with Tesslift Co. Limited.2024- Launched our own brand Exoluxe and DRS1512.- Launched our Own brand Eoluxe.- Conversion of our Company from a private limited company to a public limited company.

Our Company was originally incorporated as `Aakaar Medical Technologies Private Limited', a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated June 20, 2013 issued by the Registrar of Companies, Mumbai. Subsequently, our Company was converted into a public limited company pursuant to a resolution passed by our shareholders at an extraordinary general meeting held on July 19, 2024 and a fresh certificate of incorporation dated November 18, 2024 was issued by the Registrar of Companies, Mumbai, recording the change in the name of our Company from `Aakaar Medical Technologies Private Limited' to `Aakaar Medical Technologies Limited'.Major Events:2013- Incorporated as Aakaar Medical Technologies Private Limited.2016- Entered into licensing, marketing and distribution agreement with Medytox Inc., South Korea for launch of Siax.2017- Launched our own brands Tubelite.- Launched our own brand Balback.- Launched our own brand Lytec.2018-Entered into a tripartite agreement with ACPL and Croma Pharma GmbH for launch of Saypha filler (earlier known as Princess).2022- Launched our own brand Etrelume.2023- Launched our own brand Swyada.- Entered into exclusive agreement in licensing, marketing and distribution with Regenera Activa Worldwide S.L for launch of Regenera ActivaAMT.- Entered into exclusive agreement in licensing, marketing and distribution with Tesslift Co. Limited.2024- Launched our own brand Exoluxe and DRS1512.- Launched our Own brand Eoluxe.- Conversion of our Company from a private limited company to a public limited company.

Parent Organisation

Aakaar Medical Technologies Ltd.

Founded

20/06/2013

Managing Director

Mr.Rahul Babasaheb Sawakhande

NSE Symbol

AAKAARSM

FAQ